- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: TRELEGY ELLIPTA
Total 64 results
-
Fundacio Privada Mon Clinic BarcelonaGlaxoSmithKlineRecruiting
-
GlaxoSmithKlineRecruiting
-
Baylor Research InstituteNot yet recruiting
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Pulmonary Research Institute of Southeast MichiganGlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Spain, Netherlands, Sweden, United Kingdom
-
GlaxoSmithKlineWithdrawnLegend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study (LEGEND)Pulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineRecruitingAsthmaUnited States, Canada, Argentina, Australia, Japan, Korea, Republic of, Taiwan
-
Thammasat UniversityNot yet recruitingChronic Obstructive Pulmonary Disease
-
GlaxoSmithKlineRecruiting
-
University of VirginiaRecruitingChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveIndia
-
Dr. Grace ParragaGlaxoSmithKlineActive, not recruiting
-
Dr. Anil K. Gupta Medicine Professional CorporationEnrolling by invitation
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Japan, Poland, Canada, Russian Federation, Spain, Germany, Hungary, South Africa, Italy, Mexico, Romania, Bulgaria, China, Lithuania
-
Università degli Studi di FerraraTerminated
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, France, Germany, Poland, Romania, Russian Federation, Spain, United States, Netherlands, Sweden, Korea, Republic of, Canada, United Kingdom, Italy, Mexico
-
GlaxoSmithKlineCompletedAsthmaUnited States, Canada, Germany, Spain, Netherlands, Italy, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaCanada, United States
-
GlaxoSmithKlineCompletedAsthmaAustralia, United States, Argentina, Canada, Germany, Japan, Korea, Republic of, Romania, Russian Federation, Spain, South Africa, Netherlands, Poland, Italy, United Kingdom
-
Bispebjerg HospitalRigshospitalet, DenmarkCompletedPharmacokineticsDenmark
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary DiseaseGermany, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveNetherlands, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Netherlands, Czechia
-
GlaxoSmithKlineOptum-data vendorCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompleted
-
University of DundeeBoehringer Ingelheim; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Gary L. PierceCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Canada, Germany, Spain, United States, Italy, Netherlands, South Africa, Sweden, France, Mexico, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
University Hospital, BordeauxWithdrawn
-
GlaxoSmithKlineRTI Health Solutions(RTI HS)Completed
-
Mundipharma Research LimitedCompletedAsthmaUnited Kingdom, Sweden, Australia, New Zealand, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Korea, Republic of, Romania, Russian Federation, Spain, Netherlands, Mexico, Brazil, Chile, Czechia
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsCompletedPulmonary Disease, Chronic Obstructive (COPD)Argentina